Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
04/2014
04/02/2014CN103690686A Herbal medicine foot-bath powder capable of treating neurasthenia and insomnia
04/02/2014CN103690666A A prescription used for treating hemicrania
04/02/2014CN103690642A Herbal footbath powder for treating beriberi
04/02/2014CN103690627A Electuary having health function of assisting to improve memory
04/02/2014CN103690626A Compound cinnamon capsules and preparation method thereof
04/02/2014CN103690605A Traditional Chinese medicine preparation for treating rheumatism
04/02/2014CN103690595A Ethyl acetate extract of radix sophorae tonkinensis, as well as preparation method, detection method and application thereof
04/02/2014CN103690589A Medicinal preparation containing albizia flower total flavone
04/02/2014CN103690583A Medicinal liquor, and preparation method and application thereof
04/02/2014CN103690581A Pharmaceutical composition for treating senile dementia
04/02/2014CN103690551A Iridoid glycoside extracts in cleavers and extraction method and medical application thereof
04/02/2014CN103690547A Application of polydatin to preparation of medicament for treating chronic alcoholism cerebral injury
04/02/2014CN103690541A Therapeutic agent for spinal canal stenosis
04/02/2014CN103690540A Controlled release hydrocodone formulations
04/02/2014CN103690539A Application of koumine and koumine homolog in preparation of medicines for treating diabetic complications
04/02/2014CN103690520A Patch containing essential oil of single leaf asarum, as well as preparation method and medical application of patch
04/02/2014CN103690516A Aripiprazole oral membrane and preparation method thereof
04/02/2014CN103690505A Hypnotic double-layer controlled release tablet and preparation method thereof
04/02/2014CN103690499A Stable crystalline form I agomelatine tablets and preparation method thereof
04/02/2014CN103690477A Levetiracetam injection
04/02/2014CN103690436A Orange flower facial mask
04/02/2014CN103330806B Drug for treatment of rheumatoid arthritis
04/02/2014CN103214382B Meclofenoxate hydrochloride compound and pharmaceutical composition thereof
04/02/2014CN103127346B Traditional Chinese medicinal composition for treating depression after stroke
04/02/2014CN103099889B Traditional Chinese medicine wine for treating lumbar spinal stenosis
04/02/2014CN103055068B Traditional Chinese medicine composition for treating severe craniocerebral injury in convalescence
04/02/2014CN103041177B Chinese medicament for treating diabetic foot
04/02/2014CN103007293B Targeting polypeptide-gene composite as well as preparation method and application of composite
04/02/2014CN103006945B Multifunctional medicinal liquor for external use
04/02/2014CN102988284B Preparation method for monosialotetrahexosyl ganglioside sodium injection
04/02/2014CN102895655B Application of haemopoietin microspheres in preparation of medicaments for treating parkinsonism
04/02/2014CN102895278B Application of arctinin and arctigenin in resisting parkinsonism
04/02/2014CN102895200B Mecobalamine freeze-drying composition and preparation method thereof
04/02/2014CN102885539B Drug pillow capable of relieving night terrors of children
04/02/2014CN102872155B Application of flavonoid glycoside compound on medicine for treating cerebral apoplexy
04/02/2014CN102813894B Preparation method of traditional Chinese medicine for treating heart blood deficiency-type insomnia
04/02/2014CN102793861B Chinese medicinal plaster for treating pain in neck, shoulders, waist and legs
04/02/2014CN102784326B Method for preparing traditional Chinese medicine for treating insomnia caused by dark urine
04/02/2014CN102784160B Application of forsythin to preparation of medicine for improving cognitive function and treating Alzheimer's diseases
04/02/2014CN102727652B Traditional Chinese medicine composition for enhancing memory as well as preparation method and application of Traditional Chinese medicine composition
04/02/2014CN102617380B Carbonic acid diester water-soluble derivant of amino acid and propofol, and application of carbonic acid diester water-soluble derivant of amino acid and propofol
04/02/2014CN102603675B Piperazine compound and application thereof
04/02/2014CN102579857B Medicament formula for treating depressive psychosis and madness (schizophrenia) and preparation method thereof
04/02/2014CN102558299B Synthetic polypeptide and application thereof
04/02/2014CN102552301B Medicine composition and application thereof
04/02/2014CN102552105B Cascade brain-targeting drug delivery system as well as preparation method and application thereof
04/02/2014CN102428069B Acrylamide compounds and the use thereof
04/02/2014CN102423437B Double-prescription medicament for treating apoplectic hemiplegia and preparation method thereof
04/02/2014CN102408395B Novel piperazine and homopiperazine derivative and preparation method and use thereof
04/02/2014CN102227427B Cyclobutyl purine derivative, angiogenesis promoting agent, lumenization promoting agent, neurocyte growth promoting agent, and drug
04/02/2014CN102212058B Single composite medicament (chiral nitrogenous heterocyclic ester) and synthesis method thereof as well as application of chiral nitrogenous heterocyclic ester in preparing low-toxicity CB1 receptor inhibitor
04/02/2014CN102180872B [1, 3 and 4] oxadiazoles derivative and application thereof
04/02/2014CN101878219B Imidazolothiadiazoles for use as protein kinase inhibitors
04/02/2014CN101875691B Scorpion arialgesic antitumoral peptide mutant and preparation method thereof
04/02/2014CN101730678B Amino acid derivatives
04/02/2014CN101585779B New crystal form of Agomelatine, preparation method and use thereof
04/02/2014CN101346357B Aminodihydrothiazine derivative
04/01/2014US8686120 DRG11-responsive (DRAGON) gene family
04/01/2014US8686047 Pharmaceutical formulations of modafinil
04/01/2014US8686002 Heterocyclic compounds and their use as binding partners for 5-HT5 receptors
04/01/2014US8685994 Analgesic combination of oxycodone and celecoxib
04/01/2014US8685967 Substituted triazolopyridines and analogs thereof
04/01/2014US8685955 Neuroprotective iron chelators and pharmaceutical compositions comprising them
04/01/2014US8685473 Pawpaw and/or peach derived composition
04/01/2014US8685437 Thin film with non-self-aggregating uniform heterogeneity and drug delivery systems made therefrom
04/01/2014US8685372 Peptides and aptamers for targeting of neuron or nerves
04/01/2014CA2749212C Isoxazole / o-pyridine derivatives with ethyl and ethenyl linker
04/01/2014CA2645946C Inhibitors of protein aggregation
04/01/2014CA2616377C Nitrocatechol derivatives as comt inhibitors
04/01/2014CA2581144C Novel pyridinone derivatives and their use as positive allosteric modulators of mglur2-receptors
04/01/2014CA2556436C Process for preparing anit-a.beta. antibody
04/01/2014CA2413354C Neurotoxic a.beta. oligomers in alzheimer's disease
03/2014
03/27/2014WO2014047323A1 Methods for treating post-traumatic stress disorder
03/27/2014WO2014047153A1 Treatment and prevention of learning and memory disorders
03/27/2014WO2014047116A1 Encapsulating liposomes
03/27/2014WO2014046544A1 Substituted 3-heteroaryloxy-3-(hetero)aryl-propylamines as serotonin transporter and serotonin ht2c receptor modulators
03/27/2014WO2014046472A1 Medicine having improved rivastigmine stability
03/27/2014WO2014046391A1 Pharmaceutical composition for treating or preventing ptpσ-mediated diseases
03/27/2014WO2014046247A1 Synthetic peptide for adjusting balance of type-1 tnf receptors and type-2 tnf receptors, and use of said peptide
03/27/2014WO2014045162A1 ALKYL-SUBSTITUTED HEXAHYDROPYRANO[3,4-d] [1,3]THIAZIN-2-ANIME COMPOUNDS
03/27/2014WO2014045156A1 Novel bicyclic pyridinones
03/27/2014WO2014045031A1 Bicyclic aza compounds as muscarinic m1 receptor agonists
03/27/2014WO2014044790A1 Methods and pharmaceutical compositions for the treatment and prevention of hypothyroidism in down syndrome (ds) patients
03/27/2014WO2014044721A1 Novel crystalline form of vortioxetine hydrobromide
03/27/2014WO2014006528A3 Compositions and methods for the treatment of neurological degenerative disorders
03/27/2014WO2013181618A3 Methods to treat alzheimer's disease using apoe inhibitors
03/27/2014US20140088183 Isolation of a dual cox-2 and 5-lipoxygenase inhibitor from acacia
03/27/2014US20140088176 Gene transfer for regulating smooth muscle tone
03/27/2014US20140088131 Implantable Polymeric Device for Sustained Release of Buprenorphine
03/27/2014US20140088126 Rosuvastatin Enantiomer Compounds
03/27/2014US20140088108 2-(3-aminoaryl) amino-4-aryl-thiazoles and their use as c-kit inhibitiors
03/27/2014US20140088009 Chimeric neuregulins and method of making and use thereof
03/27/2014US20140087470 Reversible immortalization
03/27/2014US20140087422 Nucleic acids related to fusion proteins
03/27/2014US20140086978 Transdermal Therapeutic System Provided With Improved Long-Term Carrying Comfort
03/27/2014US20140086972 Microfabricated nanopore device for sustained release of therapeutic agent
03/27/2014US20140086937 Immunological control of beta-amyloid levels in vivo
03/27/2014DE102012018789A1 New N-isopropylcarbamate compound is phospholipase A2 inhibitor, useful for prophylactic and/or therapeutic treatment of diseases e.g. inflammation, psoriasis, cerebral ischemia, Alzheimer's disease, chronic skin diseases and thrombosis
03/26/2014EP2711705A1 Oxidized cardiolipin as a novel pro-inflammatory factor
03/26/2014EP2711419A1 Cell differentiation inducer and differentiation inducing method
1 ... 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 ... 1833